GETI.B

211.8

+0.38%↑

CAMX

691

-0.5%↓

BIOAB

278.6

+2.96%↑

EKTA.B

49.58

+0.16%↑

AMBEA

130.7

+0.23%↑

GETI.B

211.8

+0.38%↑

CAMX

691

-0.5%↓

BIOAB

278.6

+2.96%↑

EKTA.B

49.58

+0.16%↑

AMBEA

130.7

+0.23%↑

GETI.B

211.8

+0.38%↑

CAMX

691

-0.5%↓

BIOAB

278.6

+2.96%↑

EKTA.B

49.58

+0.16%↑

AMBEA

130.7

+0.23%↑

GETI.B

211.8

+0.38%↑

CAMX

691

-0.5%↓

BIOAB

278.6

+2.96%↑

EKTA.B

49.58

+0.16%↑

AMBEA

130.7

+0.23%↑

GETI.B

211.8

+0.38%↑

CAMX

691

-0.5%↓

BIOAB

278.6

+2.96%↑

EKTA.B

49.58

+0.16%↑

AMBEA

130.7

+0.23%↑

Home・Aandelen Lijst・Vitrolife AB

V
Vitrolife AB

Open

131.1 -3.6

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

127.6

Max

137.6

Belangrijke statistieken
By Trading Economics
Inkomsten	31M 132M
Verkoop	29M 871M
K/W Sectorgemiddelde	40.149 35.293
EPS	0.74
Dividendrendement	0.81
Winstmarge	15.155
Werknemers	1,147
EBITDA	-119M 137M

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	0.81% 3.07%
Volgende Winsten	23 okt 2025

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-1.7B 18B
Vorige openingsprijs	134.7
Vorige sluitingsprijs	131.1

Vitrolife AB Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 sep 2025, 17:03 UTC

Belangrijke Marktbewegers

BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment

16 sep 2025, 16:49 UTC

Belangrijke Marktbewegers

Acquisities, Fusies, Overnames

GD Culture Shares Drop After Deal for Pallas Capital

16 sep 2025, 16:11 UTC

Belangrijke Marktbewegers

Corbus Shares Rise on FDA Fast-Track Designation for Cancer Drug

16 sep 2025, 23:40 UTC

Marktinformatie

Nikkei May Decline as Yen Strengthens -- Market Talk

16 sep 2025, 23:34 UTC

Marktinformatie

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

16 sep 2025, 23:20 UTC

Marktinformatie

Restaurant Brands NZ Can Outperform When Cycle Turns -- Market Talk

16 sep 2025, 21:10 UTC

Acquisities, Fusies, Overnames

U.S. Investors, Trump Close In on TikTok Deal With China -- WSJ

16 sep 2025, 20:51 UTC

Marktinformatie

U.S. Home Sales, New Home Listings Fall in August -- Market Talk

16 sep 2025, 20:50 UTC

Marktinformatie

Energy & Utilities Roundup: Market Talk

16 sep 2025, 20:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

16 sep 2025, 20:25 UTC

Winsten

The AI Trade Has Stocks Near Highs Again. Some Tech Names Remain on the Sidelines -- Barrons.com

16 sep 2025, 20:24 UTC

Winsten

These Stocks Moved the Most Today: Oracle, Tesla, Alphabet, Dave & Buster's, Chipotle, and More -- Barrons.com

16 sep 2025, 19:19 UTC

Marktinformatie

U.S. Natural Gas Futures Extend Winning Streak -- Market Talk

16 sep 2025, 18:52 UTC

Marktinformatie

Oil Futures Advance on Russia Concerns, Weak Dollar -- Market Talk

16 sep 2025, 18:44 UTC

Marktinformatie

Global Equities Roundup: Market Talk

16 sep 2025, 18:44 UTC

Marktinformatie

EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk

16 sep 2025, 18:40 UTC

Acquisities, Fusies, Overnames

Details Emerge on U.S.-China TikTok Deal -- WSJ

16 sep 2025, 18:38 UTC

Marktinformatie

Meta Seen With Long-Term Opportunity to Lead in Smart Glasses -- Market Talk

16 sep 2025, 18:19 UTC

Marktinformatie

Gold Settles at New High Ahead of Fed Decision -- Market Talk

16 sep 2025, 18:01 UTC

Marktinformatie

U.S. Dollar Weakness Supports Oil's Gains -- Market Talk

16 sep 2025, 17:34 UTC

Marktinformatie

Any Question the Bank of Canada Will Cut Now Look to Have Vanished -- Market Talk

16 sep 2025, 16:53 UTC

Winsten

Software Companies Are Fighting Back With AI. The Stocks Are Still Hurting. -- Barrons.com

16 sep 2025, 16:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

16 sep 2025, 16:15 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Global Commodities Roundup: Market Talk

16 sep 2025, 16:09 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Global Energy Roundup: Market Talk

16 sep 2025, 16:09 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Canada Industry Minister to Meet Mining CEOs on Merger -- Market Talk

16 sep 2025, 15:35 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

16 sep 2025, 15:35 UTC

Marktinformatie

Gold Soars Past $3,700 Ahead of Fed Decision -- Market Talk

16 sep 2025, 15:22 UTC

Marktinformatie

More Investors Think Dollar is Overvalued in Latest BofA Survey -- Market Talk

16 sep 2025, 15:21 UTC

Marktinformatie

Sterling Considered Most Overvalued in Nearly 10 Years -- Market Talk

Peer Vergelijking

Prijswijziging

Vitrolife AB Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.